ALL Management Guideline

Could CAR-T cell therapy be promising agent in acute lymphoblastic leukemia?

T- Acute lymphoblastic leukemia: Does our understanding of molecular pathogenesis will impact future treatment?

Prognostic factors, lines of treatment, and outcome of relapsed pediatric lymphoblastic lymphoma in Children Cancer Hospital Egypt

Dendritic cells in cancer immunotherapy from bench to clinic

Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute

Updates in Cancer Immunotherapy: Review Article

Management of FLT-3 mutated AML

The Outcome of Acute Lymphoblastic Leukemia in Infants at National Cancer Institute Egypt: 10 Years Experience

Expression of programmed death ligand-1 in B-cell acute lymphoblastic leukemia